| Literature DB >> 35789441 |
Ahmed Mahjoub1, Nadia Ben Abdesslem1, Ilhem Sellem2, Nesrine Zaafrane1, Anis Mahjoub1, Fatma Sakji1, Mohamed Ghorbel1, Hachemi Mahjoub1, Wissal Ben Yahia3, Ahmad Guiga3.
Abstract
OBJECTIVE: To report a case of Behçet's disease (BD) presenting as a panuveitis with neuroretinitis and pre-papillary vitreous infiltrate.Entities:
Year: 2022 PMID: 35789441 PMCID: PMC9256878 DOI: 10.1186/s12348-022-00299-x
Source DB: PubMed Journal: J Ophthalmic Inflamm Infect ISSN: 1869-5760
Fig. 1A Fundus photograph of the right eye exhibiting an epiretinal membrane (black arrow) and a superotemporal bundle retinal fiber layer defect (white arrows). B Fundus photograph of the left eye showing a vitreous opacity overlying the optic nerve head, multiple dot and blot retinal hemorrhages and a vascular sheathing with frosted branch appearance
Fig. 2Fundus fluorescein angiography: A Early phase revealing delay of filling of the infero-temporal branch retinal vein. B Late phase showing hypofluorescence of the optic disc due to the masking effect of vitreous opacity overlying the papillary area, staining of the inferotemporal vein wall as well as vascular leakage of fluorescein dye
Fig. 3Initial SS OCT scan through the left optic disc exhibiting a hyperreflective lesion in the pre-papillary vitreous area corresponding to the pre-papillary vitreous infiltrate (red arrow) as well as an important optic disc swelling with a large serous retinal detachment extending to the macula (blue arrow)
Fig. 4Repeat fundus photographs and optic nerve SS OCT exhibiting the resolution of the pre-papillary vitreous infiltrate under treatment. (A) 2 days after the initiation of the treatment, the “funnel shaped” feature of the infiltrate is well-defined on the SS OCT as a hyperreflective lesion in the pre-papillary vitreous and the serous retinal detachment resolved. (B) Repeat SS OCT at day 6 showing that the pre-papillary vitreous infiltrate started resolving noticeably. (C) Follow-up at day 15, optic disc SS OCT revealing that the pre-papillary vitreous infiltrate resolved completely
Fig. 5Retinal nerve fibre layer report showing defects in both eyes. A right eye; B left eye
Summary of the cases of Behçet’s disease uveitis associated with a pre-papillary vitreous infiltrate reported in literature
| | Age (years) | Sex | Behçet’s disease symptoms | Background treatment | Treatment of the current episode | Time to resolution of the pre-papillary vitreous infiltrate |
|---|---|---|---|---|---|---|
| Nakamura et al. [ | 34 | Female | Neuro Behçet’s disease, mucocutaneous lesions and uveitis. | -Prednisolone 25 mg/ day. -Colchicine 1 mg/day. | -Subtenon injection of 0.3 ml dexamethasone. -Augmentation of colchicine dosage to 1.5 mg/day. | 11 days. |
| Schwartz et al. [ | 23 | Male | Neuro Behçet’s disease and uveitis. | -Prednisone 12.5 mg/day. -Azathioprine 150 mg/day. | -Augmentation of prednisone dosage to 60 mg/day. | 7 days. |
| Grotting et al. [ | 46 | Female | Mucocutaneous lesions and uveitis. | - (Infliximab infusions stopped 1 year before flare-up). | -IV Methylprednisolone 500 mg/day then oral prednisone 60 mg/day. | 2 months. |
| 36 | Male | Mucocutaneous lesions and uveitis. | -Prednisone 60 mg/day. | -IV Methylprednisolone 1 g/day. -Sub-tenon injection of Triamcinolone. | 4 months. | |
| 26 | Male | Pericarditis and uveitis. | -Azathioprine 200 mg/day. | -Prednisone 60 mg/day. -Adalimumab. | 3 weeks. | |
| Tugal-Tutkun et al. [ | 37 | Female | Uveitis (No additional details). | Not mentioned. | Not mentioned. | 6 months. |
| 35 | Female | Uveitis (No additional details). | Not mentioned. | Not mentioned. | 3 weeks. | |
| Ksiaa et al. [ | 37 | Male | Mucocutaneous lesions and uveitis. | – | -Prednisone 1 mg/kg/day. -Azathioprine 3 mg/kg/day. | 1 month. |
| Our case | 43 | Male | Mucocutaneous lesions and uveitis. | – | -IV Methylprednisolone 1 g/ per day for 3 days then oral prednisone 1 mg/kg/day. -Azathioprine 150 mg/day. -Ciclosporin 200 mg/day | 15 days. |